Empowering patient advocates and researchers: The EURORDIS Open Academy’s new era in rare disease training

blank

The EURORDIS Open Academy accompanies patient advocates and researchers by offering rare disease-specific comprehensive training programmes that empower them with the knowledge, skills and confidence they need to engage with different stakeholders as equal partners.

Since 2008, EURORDIS has been providing training programmes aimed at empowering patients and researchers to ensure they have the confidence and knowledge needed to bring their expertise to discussions on health care, research and medicines development with policy makers and industry, clinical diagnosis and data in rare disease research. As of 2024, the Open Academy has trained more than 800 patient advocates in person from 51 countries and over 4350 people from 166 countries have benefited from the e-learning.

The EURORDIS Open Academy enters a new era under the European Rare Diseases Research Alliance (ERDERA) partnership. The Open Academy Schools 2025 (https://openacademy.eurordis.org/open-academy-schools-2025/) offer three different training programmes for patient advocates and young researchers with a blended learning approach, including eLearning courses, webinars and in-person training as well as research visits and networking opportunities on medicines research and development, scientific innovation and translational research, and the fundamentals of rare disease research data.

See more

News & Updates

You might also be interested in

ERDERA interviews Prof. Radka Kaneva and Dr Petia Stratieva, two leading members of Bulgaria’s National Mirror Group (NMG), to explore how the country is working to align its rare disease ecosystem with European developments.
ERDERA joins the Wilhelm Foundation and the Gdansk Medical University and Clinical Centre to strengthen phenotype‑led diagnosis for people living with undiagnosed conditions
The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.
Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.